LaraKRotter

Lara K Rotter | PGY-3 | Physician-Scientist Track @YaleIMed | Critical Care/TxID | Former Research Fellow @DanaFarber @harvardme @sloan_kettering

[Mark D. Siegel @MarkDSiegel1]

Congratulations to @TradIMYale PGY3 @LaraKimR and attending Marwan Azar! @YaleIMed

[LaraKRotter @LaraKimR]

CCADV (CT Alliance and The Connecticut Coalition Against Domestic Violence)

[LaraKRotter @LaraKimR]

Our first session on Intimate Partner Violence for our residents!A series I was inspired to start by our amazing PD @MarkSiegel1.Grateful for the phenomenal teamwork: Ms.Schippiani(CCADV) and Drs.McNamara, Savage&Sharninghausen.Making a difference together!💪@TradIMYale @YaleIMed

[LaraKRotter @LaraKimR]

Grateful to be part of this incredible group — our expanding force of Physician-Scientists! @YaleMedPSTP @TradIMYale @MarkDSiegel1

[Silvia Vilarinho @VilarinhoSilvia]

Happy Holidays from @YaleMedPSTP !

Cheers to Physician-Scientists!

[LaraKRotter @LaraKimR]

After our recent study on why many clinical trials end prematurely (https://t.co/cCDSe7q5rd), we set our focus on Global Disparities in Leukemia Clinical Trials (https://t.co/zcCX5gDPXl).Thanks to our phenomenal team! @Alhajahjeh_Abd @Dr_AmerZeidan...
@YaleMedPSTP @MarkDSiegel1

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials https://t.co/nbORcdmn3S

[Yale ID Fellows @YaleIDFellows]

No words can express how lucky, grateful our trainees have been to have Dr. Marwan Azar as our program director! Will miss him greatly - wishing you all the success on your next career endeavors!! #IDTwitter #MedTwitter

[Abdulrahman Alhajahjeh, MD @Alhajahjeh_Abd]

This is a very critical issue for me especially as one of my friend's brothers has recently passed away due to a lack of access to one of the novel leukemia medications that might help him. I'm thankful for the great support of @Dr_AmerZeidan @MaxStahlMD and @LaraKimR

[Abdulrahman Alhajahjeh, MD @Alhajahjeh_Abd]

Big thanks to @LaraKimR for her phenomenal work and to @Dr_AmerZeidan for the incredible support all the way!! Very excited for the next😁

[LaraKRotter @LaraKimR]

@Dr_AmerZeidan @YaleMed @Alhajahjeh_Abd Wondering why so many clinical trials end prematurely? Our latest research digs into this critical issue. This work would not have been possible without such an excellent team @Alhajahjeh_Abd @JMStempel @Dr_AmerZeidan @MaxStahlMD @BewersdorfJan...@TradIMYale @YaleMedPSTP

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials https://t.co/nbORcdmn3S

[Jatin M. Vyas, MD, PhD @jmvyasmdphd]

So excited to join @ColumbiaMed! I have focused my career on supporting the next generation in academic med. The Vagelos Institute for Biomedical Research Education will leverage strengths of @Columbia to build the best environment for physician-scientists from UME to faculty!

[Mark D. Siegel @MarkDSiegel1]

So proud of @TradIMYale PGY3 @LaraKimR making a splash at IDSA! Watch out NIH! @YaleIMed @YaleIDFellows

[Yale ID Fellows @YaleIDFellows]

Not one, but TWO Challenging Case presentations by the fabulous Maria Koshy (2nd year fellow) and Lara Rotter @LaraKimR (3rd year IM resident) 2/5

[LaraKRotter @LaraKimR]

Thrilled to have presented a compelling case at the intersection of transplant ID and critical care! Grateful for the inspiring connections and unwavering support and trust, especially from Dr.Marwan Azar.This opportunity truly means a lot! @YaleIDFellows @YaleMedPSTP @TradIMYale

[Mark D. Siegel @MarkDSiegel1]

Pics of our beautiful city, just in time for @TradIMYale interview season. @YaleIMed

[Yale IM Traditional Residency Program @TradIMYale]

Looking forward to seeing you all!

In the sign-up form, you can drop your questions, and we will be happy to answer them during the events.

[LaraKRotter @LaraKimR]

@MarkDSiegel1 @TradIMYale @annareisman Thank you to @annareisman, @LisaSandersmd, Dr. Sharon Ostfeld-Johns, @VQuagliarello for the chance to share this at MGR. Excited to develop new educational sessions on IPV for our residents @TradIMYale. Thank you @MarkDSiegel1 .

[LaraKRotter @LaraKimR]

https://t.co/VUg29bSqHr; https://t.co/eu8EuSdAlD; https://t.co/yIL91ChpV7.

[LaraKRotter @LaraKimR]

Grateful for the opportunity to raise awareness about IPV via @NEJM. IPV is a significant cause of death for women - 1/3 globally, US: 50% female victims killed by current/former partner. IPV is linked to 6% of suicides.

[Mark D. Siegel @MarkDSiegel1]

Thank you Lara Rotter @TradIMYale PGY3 for sharing this heartbreaking story. A must read. @TradIMYale @annareisman

https://t.co/PlFQevr9Nk